The most common practical error is not the schedule at all — it is losing track of which step you are on after a break, and then resuming at the top rather than re-approaching it.
Not the answer, but possibly the question that gets there.
Topic summary
Coming back to: Where the four-week escalation interval comes from, and what it is not
This is a generated summary. It shows the 7 most-liked posts from a topic of 49, in their original order, with the accepted answer included where one exists. It is a reading aid and it will miss nuance — the full topic is the record.
Post #25 describes the usual case. This is about the unusual one.
I read the earlier replies on four-week escalation interval twice before writing this, because I had assumed the opposite and wanted to be sure I was disagreeing with what was said rather than what I expected.
30 likes 13d
e.okafor, post #9: My understanding of four-week escalation interval is a few years old and may have been superseded. If it has been, I would genuinely like to know rather than keep repeating it. Go to post
Reading back through the four-week escalation interval threads from last year, the same three questions come up every time and only one of them has ever been answered properly. That seems like a documentation gap rather than a knowledge gap.
k.laurent, post #34: Nothing to add on the substance. Thank you for taking the question at face value. Go to post
The four-week escalation interval is a convention from the pivotal trials, not a pharmacological constant. The pharmacological argument is that with a week-long half-life, four weeks approaches steady state and you can assess the dose fairly. That is an argument for not going faster. It is not an argument against going slower.
I would put the burden of proof on the interesting explanation, not the dull one.
a.weiss, post #36: On four-week escalation interval: the maintained page in the documentation commons covers the general case with citations and a review date, which is more reliable than any reply here including this one. Go to post
Concentration and dose get conflated constantly in this subcategory. Changing how much diluent you add changes the volume you draw and changes nothing about the dose.
The right answer here may simply be that it has not been measured.
Read the full topic (49 posts)
This topic was referenced in
- Micro-titration: a disputed topic, argued properlyPractice › Dosing & titration · 110 replies
Suggested topics
| Topic | Participants | Replies | Views | Activity |
|---|---|---|---|---|
|
When a dose reduction is the correct response to a side effect — a second dataset
When a dose reduction is the correct response to a side effect — a second dataset I have a specific reason for asking rather than idle curiosity, and the context is below. Posting a small dataset on dose…
|
+10 | 14 | 42k | 2mo |
|
The lowest dose that does anything: is that a real question?
Asking directly, because I could not find a straight answer: The lowest dose that does anything: is that a real question? I have read the maintained page on this and I still have a gap, so I am asking rather…
|
+100 | 111 | 9.1k | 5mo |
|
Follow-up: Where the four-week escalation interval comes from, and what it is not
Where the four-week escalation interval comes from, and what it is not Writing it up because I had to work it out twice and would rather nobody else did. A follow-up question about four-week escalation…
|
+131 | 147 | 47k | 18mo |
|
[2026 update] What steady state means for the decision to escalate
The question in the title: What steady state means for the decision to escalate I will give what I have already checked below so nobody repeats it. Asking about steady state directly, because I have read four…
|
+127 | 137 | 32k | 8mo |
|
[2026 update] Dose numbers across compounds are not on the same scale
On the subject in the title: Dose numbers across compounds are not on the same scale Working notes rather than a conclusion. A narrow question about Dose numbers across compounds, deliberately narrow, because…
|
+14 | 18 | 1.2k | 13mo |
Related topics — sharing the tags dose reduction, semaglutide, titration
| Topic | Participants | Replies | Views | Activity |
|---|---|---|---|---|
|
Follow-up: Why the titration planner refuses to produce a schedule below a floor
The question in the title: Why the titration planner refuses to produce a schedule below a floor I will give what I have already checked below so nobody repeats it. A follow-up question about titration…
|
+120 | 146 | 14k | 10mo |
|
A partial dose because the pen emptied mid-injection
A partial dose because the pen emptied mid-injection Writing it up because I had to work it out twice and would rather nobody else did. A methods question rather than a substantive one, about partial dose…
|
+108 | 120 | 1.5k | 7mo |
|
Reaching a dose and staying there for a year: a longitudinal note — does this still hold?
Asking directly, because I could not find a straight answer: Reaching a dose and staying there for a year: a longitudinal note — does this still hold? I have read the maintained page on this and I still have…
|
+35 | 39 | 547 | 11mo |
|
[2026 update] How much of the diluent volume the powder itself displaces
The question in the title: How much of the diluent volume the powder itself displaces I will give what I have already checked below so nobody repeats it. Writing this out with the numbers in it, because…
|
+89 | 100 | 3.2k | 8mo |
|
Micro-titration: a disputed topic, argued properly
Micro-titration: a disputed topic, argued properly Writing it up because I had to work it out twice and would rather nobody else did. Two things I would like separated before anyone answers on…
|
+99 | 110 | 61k | 2d |